← Open Payments lookup

AMANDA PRITCHETT: Open Payments

NPI 1184306011 · GREENWOOD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,219 in 84 payments from 11 companies in 2025. Trend: 2023 $3,063 · 2024 $758 · 2025 $1,219

Food & beverage: $1,219
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)25$394
Alkermes, Inc.13$307
ABBVIE INC.29$215
Teva Pharmaceuticals USA, Inc.5$98
Otsuka America Pharmaceutical, Inc.4$75
Indivior Inc.2$33
Braeburn Inc.2$30
Axsome Therapeutics, Inc.1$19
Gilead Sciences, Inc.1$17
Takeda Pharmaceuticals U.S.A., Inc.1$16

Products named: CAPLYTA, VRAYLAR, VIVITROL, ARISTADA, UZEDY, REXULTI, ABILIFY ASIMTUFII, SUBLOCADE.

Industry payments across IN — which companies pay providers there.